Skip to content

Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitis

Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1050210175
Enrollment
15
Registered
2022-02-11
Start date
2022-02-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis Atopic dermatitis

Interventions

None listed

Sponsors

Tamagawa-Mineoka Risa
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Patients who were diagnosed as atopic dermatitis following the criteria of the Japanese Dermatological Association by dermatologists, Persons who is generally judged as healthy. 2) Persons who can give voluntary written consent to participate in the present trial

Exclusion criteria

Exclusion criteria: 1) Patients with skin infection. 2) Patients who were orally administered immunosuppressant within 4 weeks prior to the study.

Design outcomes

Primary

MeasureTime frame
To identify biomarkers associated with disease severity and activity of atopic dermatitis.

Secondary

MeasureTime frame
To quantify the candidates of biomarkers in protein level.

Contacts

Public ContactRisa Tamagawa-Mineoka

Kyoto Prefectural University of Medicine

risat@koto.kpu-m.ac.jp+81-75-251-5586

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026